Table of Contents Author Guidelines Submit a Manuscript
Journal of Analytical Methods in Chemistry
Volume 2016 (2016), Article ID 9531769, 5 pages
http://dx.doi.org/10.1155/2016/9531769
Research Article

Selective and Accurate Determination Method of Propofol in Human Plasma by Mixed-Mode Cation Exchange Cartridge and GC-MS

College of Pharmacy, Kyungsung University, Busan 48434, Republic of Korea

Received 31 May 2016; Accepted 14 July 2016

Academic Editor: Núria Fontanals

Copyright © 2016 Jae Sung Pyo. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Kotani, M. Shimazawa, S. Yoshimura, T. Iwama, and H. Hara, “The experimental and clinical pharmacology of propofol, an anesthetic agent with neuroprotective properties,” CNS Neuroscience and Therapeutics, vol. 14, no. 2, pp. 95–106, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. R. J. Levy, “Clinical effects and lethal and forensic aspects of propofol,” Journal of Forensic Sciences, vol. 56, no. 1, pp. S142–S147, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Wilson, P. Canning, and E. M. Caravati, “The abuse potential of propofol,” Clinical Toxicology, vol. 48, no. 3, pp. 165–170, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Roussin, J.-L. Montastruc, and M. Lapeyre-Mestre, “Pharmacological and clinical evidences on the potential for abuse and dependence of propofol: a review of the literature,” Fundamental and Clinical Pharmacology, vol. 21, no. 5, pp. 459–466, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Teshima, H. Nagahama, K. Makino, Y. Kataoka, and R. Oishi, “Microanalysis of propofol in human serum by semi-microcolumn high-performance liquid chromatography with UV detection and solid-phase extraction,” Journal of Clinical Pharmacy and Therapeutics, vol. 26, no. 5, pp. 381–385, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. B. K. Burow, M. E. Johnson, and D. L. Packer, “Metabolic acidosis associated with propofol in the absence of other causative factors,” Anesthesiology, vol. 101, no. 1, pp. 239–241, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. J.-C. Salengros, C.-E. Velghe-Lenelle, R. Bollens, E. Engelman, and L. Barvais, “Lactic acidosis during propofol-remifentanil anesthesia in an adult,” Anesthesiology, vol. 101, no. 1, pp. 241–243, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Seo, “Forensic review of propofol induced deaths—analysis of 33 autopsied cases,” Annual Report National Forensic Service, vol. 43, no. 2, pp. 35–42, 2011 (Korean). View at Google Scholar
  9. S. Cohen, F. Lhuillier, Y. Mouloua, B. Vignal, P. Favetta, and J. Guitton, “Quantitative measurement of propofol and in main glucuroconjugate metabolites in human plasma using solid phase extraction-liquid chromatography-tandem mass spectrometry,” Journal of Chromatography B, vol. 854, no. 1-2, pp. 165–172, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Y. Lee, N.-H. Park, E.-K. Jeong et al., “Comparison of GC/MS and LC/MS methods for the analysis of propofol and its metabolites in urine,” Journal of Chromatography B, vol. 900, pp. 1–10, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Thieme, H. Sachs, G. Schelling, and C. Hornuss, “Formation of the N-methylpyridinium ether derivative of propofol to improve sensitivity, specificity and reproducibility of its detection in blood by liquid chromatography-mass spectrometry,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 877, no. 31, pp. 4055–4058, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Beaudry, S. A. Guénette, A. Winterborn, J.-F. Marier, and P. Vachon, “Development of a rapid and sensitive LC-ESI/MS/MS assay for the quantification of propofol using a simple off-line dansyl chloride derivatization reaction to enhance signal intensity,” Journal of Pharmaceutical and Biomedical Analysis, vol. 39, no. 3-4, pp. 411–417, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Vaiano, F. Mari, F. P. Busardò, and E. Bertol, “Enhancing the sensitivity of the LC-MS/MS detection of propofol in urine and blood by azo-coupling derivatization,” Analytical and Bioanalytical Chemistry, vol. 406, no. 15, pp. 3579–3587, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Vaiano, G. Serpelloni, M. Focardi, A. Fioravanti, F. Mari, and E. Bertol, “LC-MS/MS and GC-MS methods in propofol detection: evaluation of the two analytical procedures,” Forensic Science International, vol. 256, pp. 1–6, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Y. Han, “A study of analytical methods for the determination of propofol in blood,” Archives of Pharmacal Research, vol. 37, no. 2, pp. 157–167, 2014. View at Publisher · View at Google Scholar · View at Scopus